DR info

臨床試験数 : 18 / 薬物数 : 15 - (DrugBank : 8) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 17

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Acetate
   Department of Neurology, Nagoya University School of Medicine
      2003   Phase 2   JPRN-UMIN000000474   Japan;
   Department of NeurologyChiba University Graduate School of Medicine
      2008   -   JPRN-UMIN000001455   Japan;
BVS857
   Novartis Farma SpA
      2014   Phase 2   EUCTR2013-002608-15-IT   Denmark;Germany;Italy;United States;
   Novartis Pharma Services AG
      2014   Phase 2   EUCTR2013-002608-15-DK   Denmark;Germany;Italy;United States;
      2014   Phase 2   EUCTR2013-002608-15-DE   Denmark;Germany;Italy;United States;
   Novartis Pharmaceuticals
      2014   Phase 2   NCT02024932   Denmark;Germany;Italy;United States;
Clenbuterol
   AZIENDA OSPEDALIERA DI PADOVA
      2010   -   EUCTR2010-022558-18-IT   Italy;
Creatine
   Department of Neurology, Nagoya University Graduate School of Medicine
      2014   -   JPRN-UMIN000012503   Japan;
Dutasteride
   National Institute of Neurological Disorders and Stroke (NINDS)
      2006   Phase 2   NCT00303446   United States;
Electrophysiologic study
   Ramathibodi Hospital
      2008   Phase 4   NCT00851461   Thailand;
Goserelin
   Ramathibodi Hospital
      2008   Phase 4   NCT00851461   Thailand;
Leuprolide
   National Center for Research Resources (NCRR)
      1992   Phase 2   NCT00004771   -
Leuprorelin
   Department of Neurology, Nagoya University School of Medicine
      2003   Phase 2   JPRN-UMIN000000474   Japan;
   Department of NeurologyChiba University Graduate School of Medicine
      2008   -   JPRN-UMIN000001455   Japan;
Leuprorelin Acetate
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2017   -   JPRN-JapicCTI-183981   -
   Takeda
      2017   -   NCT03555578   Japan;
MONORES*30CPR 20MCG
   AZIENDA OSPEDALIERA DI PADOVA
      2010   -   EUCTR2010-022558-18-IT   Italy;
Mexiletine
   Nagoya University Graduate School of Medicine
      2017   Phase 2   JPRN-UMIN000026150   Japan;
TAP-144-SR(3M)
   Gen Sobue
      2007   Phase 3   JPRN-JMA-IIA00111   Japan;
   JASMITT Clinical Trial Office
      2012   Phase 2   JPRN-JMA-IIA00080   Japan;
      2006   Phase 3   JPRN-JMA-IIA00009   Japan;
Testosterone
   National Center for Research Resources (NCRR)
      1992   Phase 2   NCT00004771   -
Tissue biopsy
   Ramathibodi Hospital
      2008   Phase 4   NCT00851461   Thailand;